Publications by authors named "Suraya Jan"

Claim this Profile
D
Discovery of SDS-347 as a specific peptide competitive inhibitor of G9a with promising anti-cancer potential.
Suraya Jan, Mohd I Dar, Gauri Shankar, Rubiada Wani, Jagjeet Sandey

Biochim Biophys Acta Gen Subj· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation, Synthesis And Structure Determination Of Cannabidiol Derivatives And Their Cytotoxic Activities.
Yedukondalu Nalli, Suraya Jan, Gianluigi Lauro, Javeed Ur Rasool, Waseem I Lone

Nat Prod Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting EHMT2/ G9a for cancer therapy: Progress and perspective.
Suraya Jan, Mohd Ishaq Dar, Rubiada Wani, Jagjeet Sandey, Iqra Mushtaq

Eur J Pharmacol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation of human neuroblastoma cell line IMR-32 by sildenafil and its newly discovered analogue IS00384.
Mohd I Dar, Suraya Jan, G Lakshma Reddy, Rubiada Wani, Mudassir Syed

Cell Signal· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cells.
Mohd Ishaq Dar, Priya Mahajan, Suraya Jan, Shreyans K Jain, Harshita Tiwari

Eur J Pharmacol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis